S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.06%) $10.83
USD/GBP
(-0.11%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Aptose Biosciences Inc [APS.TO]

Exchange: TSX Industry: Biotechnology
Last Updated28 Mar 2024 @ 15:30

9.27% $ 2.24

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 15:30):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States...

Stats
Today's Volume 4 710.00
Average Volume 5 893.00
Market Cap 35.18M
EPS $0 ( 2024-03-26 )
Next earnings date ( $-1.200 ) 2024-05-05
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.210
ATR14 $0 (0.00%)

Aptose Biosciences Inc Correlation

10 Most Positive Correlations
IVQ.TO0.87
ME.TO0.86
IVX.V0.86
AH.TO0.859
PYR.TO0.859
NBVA.V0.851
GKO.V0.851
PLRB.V0.847
LGD.TO0.842
GBT.TO0.838
10 Most Negative Correlations
APL.V-0.878
MAGT.TO-0.872
SNC.TO-0.865
URB.TO-0.862
MCB.TO-0.86
WE.V-0.851
HSAV.TO-0.849
SJR-B.TO-0.848
HURA.TO-0.847
DRX.TO-0.844

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aptose Biosciences Inc Financials

Annual 2022
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.440
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.760
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-34.00
Q1 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.140

Financial Reports:

No articles found.

Aptose Biosciences Inc

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Phase 1/2 clinical trial to treat patients with relapsed or refractory AML. The company also develops luxeptinib, which is in Phase 1a/b clinical trial for treating patients with relapsed or refractory B-cell malignancies, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and various non-Hodgkin's lymphomas, as well as AML and HR MDS; and APL-581, a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program. It has agreements with CrystalGenomics, Inc. and OHM Oncology. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was incorporated in 1986 and is headquartered in Toronto, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators